Table 3.
SBP | DBP | PP | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Enhancer Target | NVARa | BurdenVT | BurdenCMC | SKAT | BurdenVT | BurdenCMC | SKAT | BurdenVT | BurdenCMC | SKAT |
All European-American Cohorts, N = 18,420 | ||||||||||
MTRNR2L4 | 20 | 0.028 | 0.015 | 0.144 | 0.216 | 0.007 | 0.356 | 0.014 | 0.032 | 0.113 |
RBFOX1 | 3 | 0.005 | 0.032 | 0.148 | 0.025 | 0.031 | 0.144 | 0.027 | 0.120 | 0.137 |
SLX4 | 26 | 0.046 | 0.047 | 0.026 | 0.199 | 0.365 | 0.046 | 0.081 | 0.005 | 0.055 |
NVAR: number of passed variants; only include linkage-based selected functional coding variants and available rare non-coding variants with MAF < 5% and CADD > 10